APA (7th ed.) Citation

Zimmer, L., & Utikal, J. (2015). Open‑label, multicenter, single‑arm phase II DeCOG‑study of ipilimumab in pretreated patients with different subtypes of metastatic melanoma. Journal of translational medicine, 13, . https://doi.org/10.1186/s12967-015-0716-5

Chicago Style (17th ed.) Citation

Zimmer, Lisa, and Jochen Utikal. "Open‑label, Multicenter, Single‑arm Phase II DeCOG‑study of Ipilimumab in Pretreated Patients with Different Subtypes of Metastatic Melanoma." Journal of Translational Medicine 13 (2015). https://doi.org/10.1186/s12967-015-0716-5.

MLA (9th ed.) Citation

Zimmer, Lisa, and Jochen Utikal. "Open‑label, Multicenter, Single‑arm Phase II DeCOG‑study of Ipilimumab in Pretreated Patients with Different Subtypes of Metastatic Melanoma." Journal of Translational Medicine, vol. 13, 2015, https://doi.org/10.1186/s12967-015-0716-5.